Kirkland Represents Bain Capital Tech Opportunities on Merger of DoseSpot and Arrive Health to Form Interra Health

Kirkland & Ellis advised Bain Capital Tech Opportunities as lead investor supporting the merger of DoseSpot and Arrive Health to form Interra Health, a patient-centric prescription platform. Bain Capital Tech Opportunities will serve as the majority owner of Interra Health. The company combines Arrive’s coverage and pricing network with DoseSpot’s ePrescribing and engagement capabilities to support prescribing decisions and help patients access the right medication at the lowest cost, where it works best for them.

Read the transaction press release

The Kirkland team included corporate lawyers Chris Elder, Chris Grady, Matthew O’Brien, Dominic Adduci and Thomas Ricchio; debt finance lawyers Yuli Wang and Daniel Clayman; tax lawyers Mike Carew and Allison Bray; technology & IP transactions lawyers Dan Lewis and Amber Harezlak; employment & labor lawyers R.D. Kohut and Madeline Klebanov; employee benefits lawyers Alexandra Mihalas and Daniel Coleman; executive compensation lawyers Scott Price and Karsten Busby; healthcare lawyers Dennis Williams and Micah Desaire; antitrust & competition lawyers Matt Reilly and Colin Herd; and capital markets lawyer Julia Danforth.